Predicting efficacy of neuromodulation in epilepsy
- Conditions
- Epilepsymedically refractory epilepsy10039911
- Registration Number
- NL-OMON55238
- Lead Sponsor
- Medisch Spectrum Twente
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
- Adult (>=18 year) patients with medically refractory epilepsy, who are
candidates for VNS implantation.
- Known with focal epilepsy with a (fronto)temporal seizure*onset zone (as
corroborated by EEG or magnetic resonance imaging [MRI]) or a generalized
epilepsy.
- A self*reported seizure frequency of at least one seizure per month.
- Prior brain surgery
- Cognitive impairments that causes the patient to be unable to understand the
research purpose and give informed consent.
- Exclusion criteria (for safety issues) to undergo an MRI scan
- Planned or expected MRI scan during the period where the subcutaneous
electrode is implanted
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method